Mark Johnson | VP, IR |
Stephen Davis | Chief Executive Officer |
Amanda Morgan | Senior Vice President, Chief Revenue & Customer Officer |
Charmaine Lykins | Senior Vice President, Global Product Planning & CMO |
Srdjan Stankovic | President |
Elena Ridloff | Executive Vice President & Chief Financial Officer |
Gavin Scott | JPMorgan |
Charles Duncan | Cantor Fitzgerald & Co. |
Jason Butler | JMP Securities |
Gregory Renza | RBC Capital Markets |
Neena Bitritto-Garg | Citigroup |
Jeff Hung | Morgan Stanley |
Jay Olson | Oppenheimer |
Vamil Divan | Mizuho Securities |
Tazeen Ahmad | Bank of America |
Marc Goodman | SVB Leerink |
Joseph Stringer | Needham & Company |
Danielle Brill | Raymond James |
Good day, ladies and gentlemen, and welcome to the ACADIA Pharmaceuticals Quarter 2021 Financial Results Conference Call. My name is Jonathan, and I will be your coordinator for today. At this time, all participants are in a listen-only mode. [Operator Instructions] I would now like to turn the presentation over to Mr. Mark Johnson, Vice President of Investor Relations.